Bio-Rad expands its COVID-19 offering with the Coronavirus Ag Rapid Test

Bio-Rad’s Coronavirus Ag Rapid Test, an antigen test used to detect the nucleocapsid protein antigen in SARS-CoV-2, offers new flexibility in detecting SARS-CoV-2 (the virus associated with COVID-19) and includes a quality control swab kit. The products met CE mark requirements for European markets earlier this year.

The Coronavirus Ag Rapid Test and quality control swab kits are included in the official list of antigen tests recommended by several European governments for the detection of the nucleocapsid protein, which is found in SARS-CoV-2. The rapid in vitro immunochromatographic test provides a quick and easy way to detect the SARS-CoV-2 antigen in the early stages of COVID-19 infection. Offering convenience and flexibility, the test can be used in a laboratory or in a point of care setting.

Clinical evaluation of the Coronavirus Ag Rapid Test was performed at seven test sites with 237 fresh nasal swab specimens and 865 fresh nasopharyngeal swab specimens collected and tested in a randomized blinded study. The test demonstrated high performance for both nasal and nasopharyngeal swab specimens, with 100% and 99.60% specificity, and 97.25% and 98.32% sensitivity, respectively, at the test sites.

Bio-Rad provides a wide range of products to help in the fight against COVID-19 including diagnostic screening of the virus, confirmation of test results, surveillance, as well as products that support therapy and vaccine research and development. From molecular testing using real-time PCR or Droplet Digital PCR, to immunology assays, our products offer best in class sensitivity and accuracy.

Do you use Bio-Rad Laboratories products in your lab? Write a review today for your chance to win a $400 Amazon Gift Card>>